257 related articles for article (PubMed ID: 2656865)
1. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.
Lehrer RI; Szklarek D; Barton A; Ganz T; Hamann KJ; Gleich GJ
J Immunol; 1989 Jun; 142(12):4428-34. PubMed ID: 2656865
[TBL] [Abstract][Full Text] [Related]
2. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ
J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025
[TBL] [Abstract][Full Text] [Related]
3. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.
Hamann KJ; Gleich GJ; Checkel JL; Loegering DA; McCall JW; Barker RL
J Immunol; 1990 Apr; 144(8):3166-73. PubMed ID: 2324497
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.
Zheutlin LM; Ackerman SJ; Gleich GJ; Thomas LL
J Immunol; 1984 Oct; 133(4):2180-5. PubMed ID: 6206154
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil granule proteins activate human heart mast cells.
Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
[TBL] [Abstract][Full Text] [Related]
6. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
Hamann KJ; Barker RL; Loegering DA; Gleich GJ
J Parasitol; 1987 Jun; 73(3):523-9. PubMed ID: 3598802
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of membrane damage mediated by human eosinophil cationic protein.
Young JD; Peterson CG; Venge P; Cohn ZA
Nature; 1986 Jun 5-11; 321(6070):613-6. PubMed ID: 2423882
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
[TBL] [Abstract][Full Text] [Related]
12. Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni.
Yazdanbakhsh M; Tai PC; Spry CJ; Gleich GJ; Roos D
J Immunol; 1987 May; 138(10):3443-7. PubMed ID: 3571976
[TBL] [Abstract][Full Text] [Related]
13. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni.
Ackerman SJ; Gleich GJ; Loegering DA; Richardson BA; Butterworth AE
Am J Trop Med Hyg; 1985 Jul; 34(4):735-45. PubMed ID: 4025686
[TBL] [Abstract][Full Text] [Related]
14. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
15. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation.
Peterson CG; Skoog V; Venge P
Immunobiology; 1986 Mar; 171(1-2):1-13. PubMed ID: 2940166
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil major basic protein: first identified natural heparanase-inhibiting protein.
Temkin V; Aingorn H; Puxeddu I; Goldshmidt O; Zcharia E; Gleich GJ; Vlodavsky I; Levi-Schaffer F
J Allergy Clin Immunol; 2004 Apr; 113(4):703-9. PubMed ID: 15100677
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
Weiler JM; Gleich GJ
J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
[TBL] [Abstract][Full Text] [Related]
19. Comparative toxicity of the horse eosinophil peroxidase-H2O2-halide system and granule basic proteins.
Klebanoff SJ; Agosti JM; Jörg A; Waltersdorph AM
J Immunol; 1989 Jul; 143(1):239-44. PubMed ID: 2659666
[TBL] [Abstract][Full Text] [Related]
20. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization.
Davis MD; Plager DA; George TJ; Weiss EA; Gleich GJ; Leiferman KM
J Allergy Clin Immunol; 2003 Nov; 112(5):988-94. PubMed ID: 14610493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
